Hongyuan Yu
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 5
-
- RNA modifications and cancer 7
- Epigenetics and DNA Methylation 6
- Circular RNAs in diseases 5
- Genomics, phytochemicals, and oxidative stress 3
-
- Renal cell carcinoma treatment 4
- Ferroptosis and cancer prognosis 3
- Journals
- Scientific Reports (3 papers)Free Radical Biology and Medicine (1 paper)Carbohydrate Polymers (2 papers)
- Partner nations
- China
In The Last Decade
Hongyuan Yu
43 papers receiving 650 citations
Peers
Comparison fields: 5 of 93
- Cancer Research 178
- Molecular Biology 355
- Biochemistry 28
- Pulmonary and Respiratory Medicine 119
- Pathology and Forensic Medicine 53
Countries citing papers authored by Hongyuan Yu
This map shows the geographic impact of Hongyuan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyuan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyuan Yu more than expected).
Fields of papers citing papers by Hongyuan Yu
This network shows the impact of papers produced by Hongyuan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyuan Yu. The network helps show where Hongyuan Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongyuan Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2022 | 7 | |
| 5 | 2021 | 3 | |
| 6 | 2021 | 5 | |
| 7 | 2021 | 99 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 5 | |
| 10 | 2021 | 11 | |
| 11 | 2020 | 22 | |
| 12 | 2020 | 3 | |
| 13 | 2019 | 3 | |
| 14 | 2018 | 28 | |
| 15 | 2016 | 24 | |
| 16 | 2015 | 21 | |
| 17 | 2014 | 5 | |
| 18 | 2014 | 6 | |
| 19 | 2013 | 7 | |
| 20 | 2012 | 5 |
About Hongyuan Yu
Hongyuan Yu is a scholar working on Cancer Research, Urology and Molecular Biology, having authored 46 papers that have together received 654 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (7 papers), Epigenetics and DNA Methylation (6 papers), MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (5 papers), Renal cell carcinoma treatment (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Ferroptosis and cancer prognosis (3 papers). The work is most often cited by research in Cancer Research (178 citations), Molecular Biology (355 citations) and Biochemistry (28 citations). Hongyuan Yu has collaborated with scholars based in China. Frequent co-authors include Xianjun Zhang, Junlong Liu, Xiaojun Tao, Bitian Liu, Chuize Kong, Ying Li, Sisi Chen, Shujun Fu, Guangchun He and Qiuting Zhang. Their work appears in journals such as Scientific Reports, Free Radical Biology and Medicine and Carbohydrate Polymers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.